COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018

08/08/2018 - 23:15

MINNEAPOLIS, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

Sienna Senior Living Inc. Reports 2018 Second Quarter Financial Results and Announces 2% Dividend Increase

08/08/2018 - 23:14

MARKHAM, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2018. The [...]

Helix BioPharma Corp. Closes Private Placement

08/08/2018 - 23:05

RICHMOND HILL, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Protech Home Medical Announces Proven Expertise With New Independent Board Member

08/08/2018 - 23:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]

Cidara Provides Corporate Update and Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:30

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]

Adamas Announces New Employment Inducement Grant

08/08/2018 - 22:30

EMERYVILLE, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees the option [...]

Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 22:22

Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for [...]

Teligent, Inc. Announces Second Quarter 2018 Results

08/08/2018 - 22:15

BUENA, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2018 [...]

INSYS Therapeutics Reports Second Quarter 2018 Results

08/08/2018 - 22:15

Focus remains on advancing pipeline across cannabinoid and spray platforms PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and [...]

Nephros Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:10

Quarterly Product Revenue Up 55% Year-over-Year; Total Revenue Up 59% Company Plans Uplist to National Stock Exchange Conference Call Scheduled for Today, August 8, 2018, at 4:30 PM EDT SOUTH ORANGE, N.J., Aug. 08, 2018 [...]

Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress

08/08/2018 - 22:08

Completed Initial Public Offering Raising $86.3 Million in Gross Proceeds Initiated Enrollment in Multiple-Ascending Dose Portion of Phase 1 Clinical Trial for SRK-015 On Track to Initiate Phase 2 Proof-of-Concept Study [...]

Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors

08/08/2018 - 22:06

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced that Mary Lake Polan, M.D., Ph.D., M.P.H., has been [...]

Achillion Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

- Global phase 2 clinical programs for ACH-4471 continue to expand in PNH and C3G - - Completed dosing phase 1 clinical study of ACH-5228 and initiated phase 1 study of ACH-5548 - - June 30, 2018 cash position $295.8 [...]

Zafgen to Present at the Wedbush PacGrow Healthcare Conference

08/08/2018 - 22:05

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018

08/08/2018 - 22:05

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering

08/08/2018 - 22:05

BEIJING, China and CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]

AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 15, 2018

08/08/2018 - 22:05

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

Codexis Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Aug. 08, 2018 ( [...]

Wright Medical Group N.V. Reports 2018 Second Quarter Financial Results

08/08/2018 - 22:05

Second Quarter 2018 Net Sales of $205 Million Second Quarter 2018 Net Loss From Continuing Operations of $91 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $26 Million U.S. Upper Extremities Business [...]